Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 9

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 9
---
 to issue a press release the day after the deadline announcing
whether or not the funds have been timely deposited. This structure is unlike the structure of similar blank check companies, which generally
are only permitted to extend the time period to complete an initial business combination in connection with an amendment to their amended
and restated memorandum and articles of association.

5

In addition to our
sponsor’s ability to extend our deadline to consummate an initial business combination by up to three months as described
above, we may also hold a shareholder vote at any time to amend our amended and restated memorandum and articles of association to
modify the amount of time we will have to consummate an initial business combination (as well as to modify the substance or timing
of our obligation to redeem 100% of our public shares if we have not consummated an initial business combination within the
prescribed time periods  or with respect to any other material provisions relating to shareholders’ rights or
pre-initial business combination activity). Our sponsor, executive officers, and directors have agreed that
they will not propose any such amendment unless we provide our public shareholders with the opportunity to redeem their public
shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in
the trust account, including interest earned on the funds held in the trust account (net of funds withdrawn to pay our taxes, if
any), divided by the number of then issued and outstanding public shares, subject to certain limitations. Our public
shareholders will be permitted to redeem their shares regardless of whether they abstain, vote for, vote against, or vote at all
with respect to the proposed business combination.

If we do not complete our
initial business combination within the completion window, we will (i) cease all operations except for the purpose of winding up,
(ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the
funds held in the trust account (net of funds withdrawn to pay our taxes, if any, and up to $100,000 of interest to pay dissolution expenses),
divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’
rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii